SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-December 2022.
Influenza Other Respir Viruses
; 17(9): e13173, 2023 Sep.
Article
in En
| MEDLINE
| ID: mdl-37752065
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Screening_studies
Language:
En
Journal:
Influenza Other Respir Viruses
Journal subject:
VIROLOGIA
Year:
2023
Document type:
Article
Affiliation country: